Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy.

Park, So-Hyeon; Lee, Jun-Hyuck; Yang, Seong-Bin; Lee, Dong-Nyeong; Kang, Tae-Bong; Park, Jooho

Park, So-Hyeon; Lee, Jun-Hyuck; Yang, Seong-Bin; Lee, Dong-Nyeong; Kang, Tae-Bong; Park, Jooho.

Afiliación

Park SH; Department of Applied Life Science, BK21 Program, Graduate School, Konkuk University, Chungju 27478, Republic of Korea.
Lee JH; Department of Applied Life Science, BK21 Program, Graduate School, Konkuk University, Chungju 27478, Republic of Korea.
Yang SB; Department of Applied Life Science, BK21 Program, Graduate School, Konkuk University, Chungju 27478, Republic of Korea.
Lee DN; Department of Applied Life Science, BK21 Program, Graduate School, Konkuk University, Chungju 27478, Republic of Korea.
Kang TB; Department of Applied Life Science, BK21 Program, Graduate School, Konkuk University, Chungju 27478, Republic of Korea.
Park J; Department of Applied Life Science, BK21 Program, Graduate School, Konkuk University, Chungju 27478, Republic of Korea.

Pharmaceutics ; 15(4)2023 Apr 03.

Article en En | MEDLINE | ID: mdl-37111617

Palabras clave

anticancer therapy; bioconjugate; cathepsin B; nanoparticle; peptide drug

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article